SWOG
- Country
- đēđ¸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2004-08-04
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 102
- Registration Number
- NCT00003784
- Locations
- đēđ¸
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
đēđ¸Providence Hospital - Southfield, Southfield, Michigan, United States
đēđ¸Boston Medical Center, Boston, Massachusetts, United States
S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
- First Posted Date
- 2004-08-04
- Last Posted Date
- 2012-08-22
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 24
- Registration Number
- NCT00003828
- Locations
- đēđ¸
Providence Hospital - Southfield, Southfield, Michigan, United States
đēđ¸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
đēđ¸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia
- Conditions
- Lymphoma
- Interventions
- Biological: filgrastimBiological: recombinant interferon alfaProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2004-08-03
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 9
- Registration Number
- NCT00003416
- Locations
- đēđ¸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
đēđ¸Arizona Cancer Center, Tucson, Arizona, United States
đēđ¸Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States
S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 96
- Registration Number
- NCT00003158
- Locations
- đēđ¸
CCOP - Atlanta Regional, Atlanta, Georgia, United States
đēđ¸Providence Hospital - Southfield, Southfield, Michigan, United States
đēđ¸CCOP - Columbus, Columbus, Ohio, United States
S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
- Conditions
- Adrenocortical Carcinoma
- Interventions
- First Posted Date
- 2004-07-30
- Last Posted Date
- 2012-10-05
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 13
- Registration Number
- NCT00002921
- Locations
- đēđ¸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
đēđ¸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
đēđ¸Louisiana State University Hospital - Shreveport, Shreveport, Louisiana, United States
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
- Conditions
- LeukemiaNeutropeniaThrombocytopenia
- First Posted Date
- 2004-07-29
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 50
- Registration Number
- NCT00002665
- Locations
- đēđ¸
CCOP - Dayton, Kettering, Ohio, United States
đēđ¸Boston Medical Center, Boston, Massachusetts, United States
đēđ¸Cleveland Clinic Cancer Center, Cleveland, Ohio, United States
SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2017-02-20
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 348
- Registration Number
- NCT00002495
- Locations
- đēđ¸
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
đēđ¸CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
đēđ¸CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States
SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
- Conditions
- LymphomaPsychosocial Effects of Cancer and Its Treatment
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2013-04-10
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 263
- Registration Number
- NCT00002563
- Locations
- đēđ¸
University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States
đēđ¸State University of New York - Upstate Medical University, Syracuse, New York, United States
đēđ¸Walter Reed Army Medical Center, Washington, District of Columbia, United States
S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium
- Conditions
- Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
- Interventions
- Drug: Depsipeptide
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2012-11-02
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 6
- Registration Number
- NCT00087295
S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
- Conditions
- Esophageal Cancer
- Interventions
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 98
- Registration Number
- NCT00086996
- Locations
- đēđ¸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
đēđ¸Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States
đēđ¸Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States